<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pulmonary function was studied prospectively in 25 children with <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> undergoing bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="1" pm="."><plain>Whereas 11 patients have died, only one did so primarily due to interstitial <z:hpo ids='HP_0002090'>pneumonia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Fourteen patients (56%) survived a median of at least 36 months </plain></SENT>
<SENT sid="3" pm="."><plain>Seventeen patients received pulmonary function tests (PFTs) </plain></SENT>
<SENT sid="4" pm="."><plain>Four patients transplanted for <z:hpo ids='HP_0001909'>leukemia</z:hpo> in relapse following preparation with a very intensive regimen (<z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, 200 mg/kg, total body irradiation, 1,000 rad, BCNU, <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>) developed restrictive lung changes </plain></SENT>
<SENT sid="5" pm="."><plain>Patients undergoing BMT for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0001909'>leukemia</z:hpo> in remission prepared with more commonly used and less intensive regimens maintained <z:mpath ids='MPATH_458'>normal</z:mpath> pulmonary function </plain></SENT>
<SENT sid="6" pm="."><plain>As new regimens are devised, PFTs should be utilized to characterize the pulmonary toxicity of these regimens as well </plain></SENT>
</text></document>